Wockhardt

Premium

Healthcare

20 April, 2023

Somerset bets on CDMO firm in fifth deal from second fund

Somerset Indus Capital Partners, a healthcare-focused private equity firm, has closed its fifth investment from its second fund with a ......

Premium

Finance

21 October, 2020

India Inc's legal costs slip off FY19 perch; Sun Pharma retakes top spot

India Inc’s legal expenses pace came down to a high single digit rate in 2019-20 from the fastest growth seen ......

Healthcare

13 December, 2016

Wockhardt's Huzaifa Khorakiwala to launch healthcare-focused angel fund

Huzaifa Khorakiwala, executive director at drugmaker Wockhardt, is set to float a healthcare-focused angel fund that puts him among a ......

Healthcare

06 August, 2016

USFDA bans import of drugs from Wockhardt's Ankleshwar plant

In yet another blow to drug maker Wockhardt, US Food and Drug Administration (USFDA) has banned import of products manufactured ......

Healthcare

19 December, 2013

Wockhardt raises $13.4M through IPO of European arm

Mumbai-based generic drugmaker Wockhardt Ltd has raised CHF 11.86 million ($13.37 million) in an initial public offering (IPO) through its ......

Healthcare

27 November, 2013

Wockhardt gets warning from USFDA over Chikalthana plant at Aurangabad

In another setback to Mumbai-based generic drugmaker Wockhardt Ltd, it has received an import alert from US Food and Drug ......

Healthcare

22 October, 2013

Wockhardt gets notice from UK regulator for its Daman plant

UK’s drug regulator has revoked the quality compliance certificate of Mumbai-based Wockhardt Ltd’s factory located in Nani Daman, making it ......

Healthcare

23 May, 2013

Wockhardt says FDA alert affects potential sales of $100M

Drug maker Wockhardt Ltd said up to $100 million in annualised revenue could be lost as a result of a ......